Allakos Inc. financial data

Symbol
ALLK on Nasdaq
Industry
Pharmaceutical Preparations
Location
825 Industrial Road, Suite 500, San Carlos, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K/A - Q4 2024 - Apr 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 434 % -46.9%
Debt-to-equity 63.4 % +116%
Return On Equity -0.14 % -74.7%
Return On Assets -0.08 % -32.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.2M shares +2.65%
Common Stock, Shares, Outstanding 89.6M shares +2.16%
Entity Public Float 81.7M USD -71.6%
Common Stock, Value, Issued 90K USD +2.27%
Weighted Average Number of Shares Outstanding, Basic 88.8M shares +2.3%
Weighted Average Number of Shares Outstanding, Diluted 88.8M shares +2.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 79.9M USD -47%
General and Administrative Expense 38.8M USD -14%
Operating Income (Loss) -122M USD +37.7%
Net Income (Loss) Attributable to Parent -116K USD +37.6%
Earnings Per Share, Basic -1.3 USD/shares +39.3%
Earnings Per Share, Diluted -1.3 USD/shares +39.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.8M USD -73.3%
Marketable Securities, Current 63.1M USD -39.6%
Cash, Cash Equivalents, and Short-term Investments 80.8M USD -52.7%
Assets, Current 85.6M USD -52.4%
Property, Plant and Equipment, Net 10.8M USD -67.6%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 188K USD -97%
Assets 96.6M USD -60.3%
Accounts Payable, Current 5.49M USD +211%
Accrued Liabilities, Current 12.3M USD -64.7%
Liabilities, Current 17.8M USD -51.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 17.8M USD -76.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 136K USD +172%
Retained Earnings (Accumulated Deficit) -1.23B USD -10.4%
Stockholders' Equity Attributable to Parent 78.8M USD -53.3%
Liabilities and Equity 96.6M USD -60.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.5M USD -7.97%
Net Cash Provided by (Used in) Financing Activities 132K USD -90.9%
Net Cash Provided by (Used in) Investing Activities 9.03M USD -74.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 89.6M shares +2.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.4M USD -452%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.2M USD -71.7%
Deferred Tax Assets, Valuation Allowance 402M USD +7.39%
Deferred Tax Assets, Gross 402M USD +5.53%
Operating Lease, Liability 4.16M USD -90%
Payments to Acquire Property, Plant, and Equipment 4K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -116M USD +37.6%
Lessee, Operating Lease, Liability, to be Paid 4.22M USD -93.2%
Property, Plant and Equipment, Gross 25.1M USD -47.4%
Operating Lease, Liability, Current 4.16M USD +27.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.51M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.22M USD -43.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 62K USD -99.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.73M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 272M USD +10.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 16.3M USD +8.25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.96M USD +3%
Operating Lease, Payments 1.8M USD +5.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 7.72M USD +25.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 25.6M USD -38%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%